ArticleEBioMedicine2019

FAM129B, an antioxidative protein, reduces chemosensitivity by competing with Nrf2 for Keap1 binding.

Kai-Chun Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.